[1]杨震,李晶,贾绍斌.不明原因脑卒中患者心房颤动的筛查[J].心血管病学进展,2016,(1):69-74.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.018]
　YANG Zhen,LI Jing,JIA Shaobin.Identification of Atrial Fibrillation in Patients with Cryptogenic Stroke[J].Advances in Cardiovascular Diseases,2016,(1):69-74.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.018]
点击复制

不明原因脑卒中患者心房颤动的筛查()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2016年1期
页码:
69-74
栏目:
综述
出版日期:
2016-02-20

文章信息/Info

Title:
Identification of Atrial Fibrillation in Patients with Cryptogenic Stroke
作者:
杨震1; 李晶2; 贾绍斌1
1. 宁夏医科大学总医院心脏中心,宁夏 银川 750004;
2. 北京医院老年医学部, 北京 100730
Author(s):
YANG Zhen1;  LI Jing2;  JIA Shaobin1
1. Heart Center,The General Hospital of Ningxia Medical University,Yinchuan 750004,Ningxia,China;
2.Geriatric Department, Beijing Hospital, Beijing 100730,China
关键词:
不明原因脑卒中;  心房颤动;  心电监测;  植入式循环记录仪
Keywords:
Cryptogenic stroke;  Atrial fibrillation;  Cardiac monitoring;  Insertable loop recorder
分类号:
R541.7+5; R743
DOI:
10.16806/j.cnki.issn.1004-3934.2016.01.018
文献标志码:
A
摘要:
隐匿性心房颤动是不明原因脑卒中的常见原因之一,及早识别隐匿性心房颤动并给予抗凝治疗意义重大。房性期前收缩、左心房扩大是隐匿性心房颤动最重要的预测指标。院内心电监测、常规系列12导联心电图、24小时动态心电图监测、事件监测仪、实时长程院外动态监控,尤其是植入式循环记录仪等多种方法可用于心房颤动的识别。B型利尿钠肽和基因多态性检测可帮助预测心房颤动风险。
Abstract:
Occult fibrillation is one of the common causes for cryptogenic stroke, therefore it is highly significant to identify occult fibrillation early and initiate anticoagulant therapy. Atrial premature complex and left atrial dilatation are the strongest predictors for occult fibrillation. Many approaches, such as in-hospital monitoring, standard serial electrocardiogram, Holter monitoring, event monitors, short-term and long-term cardiac outpatient monitoring and especially, insertable a cardiac loop recorder, could be used in the identification of atrial fibrillation. B type natriuretic sodium peptide and genetic polymorphism are helpful predictors of the risk for atrial fibrillation.

参考文献/References:

[1] Seet RC, Friedman PA, Rabinstei AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause[J]. Circulation,2011,124(4):477-486.
[2] Shibazaki K, Kimura K, Fujii S, et al. Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke[J]. Am J Cardiol,2012,109(9):1303-1307.
[3] Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke[J]. N Engl J Med,2012,366(2):120-129.
[4] Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke[J]. N Engl J Med,2014,370(26):2467-2477.
[5] Sussman M, Menzin J, Lin I, et al. Impact of atrial fibrillation on stroke-related healthcare costs[J]. J Am Heart Assoc,2013,2(6):e000479.
[6] Hart RG, Pearce LA, Aguilar MI. Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Ann Intern Med,2007,146(12):857-867.
[7] Cotter PE, Martin PJ, Ring L, et al. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke[J]. Neurology,2013,80(17):1546-1550.
[8] Verma A, Champagne J, Sapp J, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation(DISCERN AF):a prospective, multicenter study[J]. JAMA Intern Med,2013,173(2):149-156.
[9] Dogan U, Dogan EA, Tekinalp M, et al. P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke[J]. Int J Med Sci,2012,9(1):108-114.
[10] Yodogawa K, Seino Y, Ohara T, et al. Prediction of atrial fibrillation after ischemic stroke using P-wave signal averaged electrocardiography[J]. J Cardiol,2013,61(1):49-52.
[11] Kochhäuser S Dechering DG, Dittrich R, et al. Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke[J]. Stroke,2014,45(3):884-886.
[12] Vaziri SM, Larson MG, Benjamin EJ, et al. Echocardiographic predictors of nonrheumatic atrial fibrillation.The Framingham Heart Study[J]. Circulation,1994,89(2):724-730.
[13] Rizos T, Güntner J, Jenetzky E, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke[J]. Stroke,2012,43(10):2689-2694.
[14] Thakkar S, Bagarhatta R. Detection of paroxysmal atrial fibrillation or flutter in patients with acute ischemic stroke or transient ischemic attack by Holter monitoring[J]. Indian Heart J,2014,66(2):188-192.
[15] Barthlmy JC, Fasson-Grard S, Garnier P, et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks[J]. Ann Noninvasive Electrocardiol,2003,8(3):194-199.
[16] Jabaudon D, Sztajzel J, Sievert K, et al. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack[J]. Stroke,2004,35(7):1647-1651.
[17] Wallmann D, Tüller D, Wustmann K, et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients:an opportunity for a new diagnostic strategy[J]. Stroke,2007,38(8):2292-2294.
[18] Bhatt A, Majid A, Razak A, et al. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring[J]. Stroke Res Treat,2011,2011:172074.
[19] Kamel H, Navi BB, Elijovich L, et al. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke[J]. Stroke,2013,44(2):528-530.
[20] Boriani G, Glotzer TV, Santini M,et al. Device-detected atrial fibrillation and risk for stroke:an analysis of>10 000 patients from the SOS AF project(Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)[J]. Eur Heart J,2014,35(8):508-516.
[21] Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias[J]. Heart Rhythm,2006,3(12):1445-1452.
[22] Christensen LM, Krieger DW, Højberg S, et al.Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the SURPRISE study[J]. Eur J Neurol,2014,21(6):884-889.
[23] Etgen T, Hochreiter M, Mundel M, et al. Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report[J]. Stroke,2013,44(7):2007-2009.
[24] Ritter MA, Kochhäuser S, Duning T, et al. Occult atrial fibrillation in cryptogenic stroke:detection by 7-day electrocardiogram versus implantable cardiac monitors[J]. Stroke,2013,44(5):1449-1452.
[25] Sanna T, Diener HC, Passman RS, et al.Cryptogenic stroke and underlying atrial fibrillation[J]. N Engl J Med,2014,370(26):2478-2486.
[26] Kara K, Geisel MH, Möhlenkamp S, et al. B-type natriuretic peptide for incident atrial fibrillation—The Heinz Nixdorf Recall Study[J]. J Cardiol,2015,65(6):453-458.
[27] Kodani E, Matsumoto S, Igawa O, et al. Effect of carvedilol on reduction in heart rate in patients with chronic atrial fibrillation[J]. J Clin Med Res,2013,5(6):451-459.
[28] Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community[J]. Circulation,2010,121(2):200-207.
[29] Tada H, Shiffman D, Smith JG, et al. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke[J]. Stroke,2014,45(10):2856-2862.
[30] Lubitz SA, Lunetta KL, Lin H, et al. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese[J]. J Am Coll Cardiol,2014,63(12):1200-1210.
[31] Malik R, Bevan S, Nalls MA, et al. Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies[J]. Stroke,2014,45(2):394-402.

相似文献/References:

[1]张源,王群山.达比加群酯在器质性心脏病的心房颤动中的应用进展[J].心血管病学进展,2016,(1):27.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.008]
　ZHANG Yuan,WANG Qunshan.Advance of Research about Dabigatran Etexliate in Organic Heart Disease with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):27.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.008]
[2]张若愚,综述,殷跃辉,等.2型糖尿病及其药物对心房颤动的影响[J].心血管病学进展,2016,(4):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
　ZHANG Ruoyu,YIN Yuehui.Effect of Type 2 Diabetes Mellitus and Diabetic Drugs on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
[3]郑涛,综述,凌智瑜,等.心外膜脂肪组织与心房颤动[J].心血管病学进展,2016,(4):372.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.012]
　ZHENG Tao,LING Zhiyu.Epicardial Adipose Tissue and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):372.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.012]

备注/Memo

备注/Memo:
作者简介:杨震(1975—),副主任医师,博士,主要从事心脏电生理基础与临床。Email: yangzhen080@163.com
更新日期/Last Update: 2016-02-20